Relnopa 1500mcg/75mg Tablet SR
Marketer
Viilbery Healthcare Pvt Ltd
Salt Composition
Methylcobalamin (1500mcg) + Pregabalin (75mg)
Overview Relnopa 1500mcg/75mg Tablet SR
Gabapentinoid/Opioid SR 1500 mcg/75 mg tablets are a prescription medication for neuropathic pain management. They reduce pain by regulating nerve cell calcium channel function, promoting nerve fiber protection, and aiding in the repair of damaged nerve cells. Administered orally, with or without food, ideally at bedtime and consistently daily for therapeutic blood levels, the medication should be taken precisely as prescribed due to its potential for dependence. Missed doses should be taken promptly upon recall; complete the prescribed course, even with symptom improvement. Abrupt cessation is unsafe without physician consultation. Common side effects may include upper respiratory symptoms, increased hunger, elevated mood, trembling, visual blurring, dry mouth, lightheadedness, and drowsiness. Avoid activities demanding concentration until the drug's effects are known. Generally mild, these side effects usually subside. Potential weight gain can be mitigated with diet and exercise. Report any unusual mood shifts, new or worsening depression, or suicidal ideation to your doctor immediately. Full disclosure of all other medications is essential as interactions may reduce efficacy or alter the drug's action. Inform your physician of pregnancy, pregnancy plans, or breastfeeding.
Uses of Relnopa 1500mcg/75mg Tablet SR
Managing neuropathic pain
Major Benefits of Relnopa 1500mcg/75mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Relnopa 1500 mcg/75 mg Sustained-Release Tablets may be consumed with or without food, although consistent timing is recommended.
Common Side effects of Relnopa 1500mcg/75mg Tablet SR:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Relnopa 1500mcg/75mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The Relnopa 1500 mcg/75 mg Tablet SR should be swallowed whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent daily timing is recommended.
How Relnopa 1500mcg/75mg Tablet SR works:
Relnopa SR tablets (1500 mcg/75 mg) combine methylcobalamin, a B vitamin vital for myelin production (the protective sheath around nerves), and pregabalin, an alpha-2-delta ligand that reduces pain by regulating nerve cell calcium channels. This dual action effectively alleviates neuropathic pain stemming from nerve damage.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Relnopa 1500 mcg/75 mg extended-release tablets and alcohol may result in increased somnolence.
PregnancyCONSULT YOUR DOCTOR
The use of Relnopa 1500 mcg/75 mg Sustained-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Relnopa 1500 mcg/75 mg tablet is likely not suitable for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Relnopa 1500 mcg/75 mg Extended-Release Tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Relnopa 1500 mcg/75 mg Tablet SR cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Relnopa 1500 mcg/75 mg sustained-release tablets appears to pose minimal risk for individuals with hepatic impairment. Preliminary findings indicate dose modification may be unnecessary in this population. However, physician consultation is recommended.
What if you forget to take Relnopa 1500mcg/75mg Tablet SR :
Should you forget to take a Relnopa 1500 mcg/75 mg sustained-release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Relnopa 1500mcg/75mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
3,018 People bought this recently